Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
APx Acquisition Corp. I Market Cap
From what 0 stock analysts predict, the share price for APx Acquisition Corp. I (APXI) might decrease by 100% in the next year. This is based on a 12-month average estimation for APXI. Price targets go from $ to $. The majority of stock analysts believe APXI is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assignedAPXI 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect APx Acquisition Corp. I to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on APXI. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of APXI.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
Data Not Found! | ||||
When did it IPO
2022
Staff Count
0
Country
Mexico
Sector/Industry
Financial Services/Shell Companies
CEO
Mr. Kyle Philip Bransfield
Market Cap
$116.1M
In 2023, APXI generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that APXI's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 05 Jun 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - APX Acquisition Corp. I (NASDAQ: APXI) received a deficiency letter from Nasdaq on May 30, 2024, regarding compliance with listing qualifications.
Why It Matters - APX Acquisition Corp. I's deficiency letter from Nasdaq signals potential compliance issues, which could affect its stock price and market perception, impacting investor confidence.
Tue, 26 Mar 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - APx Acquisition Corp. I (NASDAQ: APXI) has signed a Business Combination Agreement with OmnigenicsAI Corp and MultiplAI Health Ltd, aiming to take OmnigenicsAI public upon closing.
Why It Matters - The business combination of APx Acquisition Corp. and OmnigenicsAI could create investment opportunities in the growing precision medicine sector, potentially enhancing market value and investor interest.
Thu, 28 Dec 2023
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - APX Acquisition Corp. I (NASDAQ: APXI) received a deficiency letter from Nasdaq on December 21, 2023, regarding its compliance with listing qualifications.
Why It Matters - The deficiency letter from Nasdaq signals potential delisting risks for APX Acquisition Corp. I, which may negatively impact stock price and investor confidence.
Fri, 01 Dec 2023
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - APX Acquisition Corp. I (NASDAQ: APXI) has signed a non-binding LOI for a business combination with a precision medicine company, aiming for a public listing post-completion.
Why It Matters - The announcement of a merger with a precision medicine company may enhance APX Acquisition Corp.'s growth potential and market relevance, impacting its stock performance and investor sentiment.
Thu, 25 Aug 2022
Sentiment - NEUTRAL
Source - Business Wire
Summary - APx Acquisition Corp. I (NASDAQ: APXI) received a notice from NASDAQ on August 23, 2022, regarding non-compliance with listing requirements.
Why It Matters - Non-compliance with NASDAQ listing standards raises concerns about APx's stability and future prospects, potentially affecting stock performance and investor confidence.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
